Autoimmunity in Retinitis Pigmentosa
Sponsor
Semmelweis University (Other)
Overall Status
Unknown status
CT.gov ID
NCT00433277
Collaborator
(none)
1
Study Details
Study Description
Brief Summary
Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- Clinical diagnosis of retinitis pigmentosa
Exclusion Criteria:
-
Cataract
-
Extremely low ERG wave amplitude (less than 8% of normal)
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Semmelweis University, Dept. of Ophthalmology | Budapest | Hungary | H-1085 |
Sponsors and Collaborators
- Semmelweis University
Investigators
- Study Director: Zoltán Z. Nagy, M.D., Semmelweis University, Dept. of Ophthalmology
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00433277
Other Study ID Numbers:
- KMolnar
First Posted:
Feb 9, 2007
Last Update Posted:
Feb 9, 2007
Last Verified:
Feb 1, 2007
Additional relevant MeSH terms: